1 year return (CAGR)
117.52%
Design Therapeutics Inc Exchange (NASDAQ, USD)
DSGN
13.16
+0.61 (+4.86%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
72.36%
5 year return (CAGR)
-4.04%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
823.57M
Price/Sales
-
Ent value
823.94M
Price/Book
4.08
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
31.94%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.59 |
| Daily high | 13.29 |
| Daily low | 12.51 |
| Daily Volume | 507K |
| All-time high | 41.49 |
| 1y analyst estimate | 21.00 |
| Beta | 1.64 |
| EPS (TTM) | -1.13 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 17 Mar 2026 |
Downside potential
Loading...
Downside potential data
| DSGN | S&P500 | |
| Current price drop from All-time high | -68.28% | -0.58% |
| Highest price drop | -95.20% | -56.47% |
| Date of highest drop | 9 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -75.99% | -10.68% |
| Avg time to new high | 690 days | 12 days |
| Max time to new high | 1379 days | 1805 days |
News
